Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants.
Antimicrob Agents Chemother
; 62(1)2018 01.
Article
em En
| MEDLINE
| ID: mdl-29061746
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinolinas
/
Malária Falciparum
/
Artemisininas
/
Antimaláricos
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article